Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 31 October 2024

 
 
 
   

IMAGINE a healthier, more competitive Europe

Watch Lars Fruergaard Jørgensen, CEO of Novo Nordisk and President of EFPIA, as he addresses how to advance health and competitiveness in Portugal and Europe.
 
 
 
 
   

Blogs
 

Around the world of evidence synthesis (in eighty pages): the methodological and practical...
29 October 2024

Application of the European HTA Regulation is around the corner - in only a few months from now, the first products... Read more

Chasing bold goals to unlock new solutions
28 October 2024

Learn more about Timothy Radstake, Vice President and Global Head of Immunology Discovery Research at AbbVie, and his... Read more
 
 
 
   

Why Clinical Trials are important: Nora's story

Nora was diagnosed with spinal muscular atrophy (SMA) when she was still a baby. At 15, she joined a clinical trial for her own and other kids’ health, at a time when there were no treatments.

Watch Nora’s story and read more about clinical trials in Europe in our report.
 
 
 
 
   

Events
 

Oxford Health Policy Forum - Let's Start
07 November 2024 (Virtual Event)

Registration is open for the online policy event "Let's Start", organised by the Oxford Health Policy Forum, which brings... Read more

Health Technology Assessment in Europe, Transformation, Performance?
08 November 2024 (Strasbourg)

The aim of this european meeting is to discuss the ongoing implementation and to forecast systemic consequences of the... Read more
 
 
 
   

EFPIA position on the use of artificial intelligence in the medicinal product lifecycle

AI will have a growing role in the research, development and manufacturing of medicines. To unlock this potential, it is crucial that regulatory frameworks governing the use of AI in the medicine development lifecycle are tailored, fit for purpose, risk-based, non-duplicative, and globally aligned.

Find out more in our paper.
 
 
 
 
   

What we are reading
 
EU lagging US and China on clinical trials - report
On 30 October 2024 (Euronews)

Europe has been falling behind on clinical trials over the past decade as pharmaceutical companies shift their focus... Read more
HCPs rank pharma in top sectors for trust, says Ipsos
On 21 October 2024 (EMJ)

Healthcare professionals’ trust in the pharmaceutical industry has risen by 8% since... Read more
Recommendations for the EU Life sciences Strategy
On 01 October 2024 (Nordic Pharma Associations)

On 1 October, the Nordic pharmaceutical associations held a seminar in Brussels on the... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu
EFPIA 2024 All rights reserved Disclaimer